Funder: British Heart Foundation
Due Dates: October 22, 2026 (Preliminary) | January 13, 2027 (Full) | February 11, 2027 (Preliminary) | April 22, 2027 (Preliminary) | June 30, 2027 (Full) | August 26, 2027 (Preliminary) | October 21, 2027 (Preliminary)
Funding Amounts: No formal funding cap; studies costing more than £500,000 or lasting more than 4 years; duration usually 4+ years
Summary: Supports cardiovascular clinical trials and hypothesis-led observational studies designed to change clinical management and improve patient care.
Key Information: The principal investigator must work in an established UK research institution and have substantial trial-management experience.
Description
British Heart Foundation Clinical Study Grants support ambitious, practice-changing research addressing defined questions in cardiovascular care. Interventional studies test interventions or pathways for prevention, diagnosis and treatment, usually through phase III or IV trials. These may investigate drugs, surgery, devices, or psychological, physical and educational interventions. Mechanistic evaluations can be included within trials or observational studies.
Observational studies must focus on specific patient populations, usually recruited within the NHS, and test hypotheses over a fixed timescale. Their predefined outcomes should directly change clinical management or inform a trial of an intervention. BHF encourages national and international collaboration where needed to deliver studies with an impact on patient care. The scheme does not support open-ended epidemiological cohorts or studies primarily focused on genetics, genomics or other omics analyses.
